Participated · Series B · Oct 2021

Zerigo Health provides an FDA-cleared, connected light therapy solution that enables Americans living with psoriasis, vitiligo, and eczema to self-administer narrowband ultraviolet B (NB-UVB) phototherapy at home or on the go. The core product is a handheld device paired with a smartphone app; prescription dosing is controlled via secure cloud-based technology and patients are remotely monitored and given personal coaching and support. The system aligns with American Academy of Dermatology guideline-recommended NB-UVB phototherapy and is designed to keep physicians and patients connected with personalized data and insights. The company said it will use the newly raised funds to expand its business reach. Zerigo raised $43M in a Series B round led by 7wireVentures. John E. Schellhorn is President and CEO, and the company is based in San Diego, California. Clarify Medical develops the Clarify Home Light Therapy System, a connected phototherapy device that uses a patient’s smartphone app to manage targeted narrowband UVB treatments. The FDA‑cleared System controls dose, frequency, and duration while monitoring dosing, adherence, patient progress, and satisfaction via cloud connectivity. Treatments are prescribed by physicians but administered at home with clinical precision, enabling remote physician oversight. The company has established Medicare coverage and says the System is now available nationally in the U.S. Clarify intends to use recent financing to commercialize the product, improve market access, and build awareness within the medical dermatology community. The announcement highlights a U.S. patient population of about 30 million people with psoriasis, vitiligo, and eczema and roughly 5,400 medical dermatologists.

Participated · Series B · Sep 2019

Vim is a technology company that connects data to workflow at health care’s "last mile": within clinical operations at the point of patient care. Its modular products—Quality Gaps, Diagnosis Gaps, Referral Guidance, and Digital Scheduling—integrate with existing clinical systems to support value-based care programs. Vim’s solutions are used by leading health plans, providers, and pharmacies to reduce burden and improve quality, experience, and total cost of care. The company emphasizes point-of-care integrations and data-aligned workflows to enable real-time decision support for clinicians and plan-provider alignment. Vim plans to accelerate rollout of its point-of-care integration technology and continue commercial growth across health plan and provider groups. Founded in 2015 and headquartered in San Francisco, Vim positions itself to power affordable, high-quality health care through seamless connectivity. Vim provides a platform that helps health plans and care providers collaborate to promote affordable, convenient, high-quality care by helping doctors choose the right providers and guiding patients to optimal providers via online booking. The platform is powered by collective intelligence from health care data and human expertise and delivers actionable insights to providers. Vim says it already has access to 10,000,000 lives and 150,000 providers through major health plan partners. The company will use new funding to fuel rapid expansion into new U.S. markets and to accelerate product development and hiring. Vim’s proposition centers on reducing the complexity of navigating the health care system and aligning stakeholders around value-based care.